Verification of the Cross Immunoreactivity of A60, a Mouse Monoclonal Antibody against Neuronal Nuclear Protein by Shanping Mao et al.
ORIGINAL RESEARCH
published: 13 May 2016
doi: 10.3389/fnana.2016.00054
Verification of the Cross
Immunoreactivity of A60, a Mouse
Monoclonal Antibody against
Neuronal Nuclear Protein
Shanping Mao 1, Guoxiang Xiong 2*, Lei Zhang 2, Huimin Dong 1, Baohui Liu 1,
Noam A. Cohen 3,4 and Akiva S. Cohen 2,5
1 Department of Neurology, Renmin Hospital, Wuhan University, Wuhan, China, 2 Department of Anesthesiology and Critical
Care Medicine, Children’s Hospital of Philadelphia, University of Pennslyvania, Philadelphia, PA, USA, 3 Philadelphia Veterans
Affairs Medical Center, University of Pennslyvania, Philadelphia, PA, USA, 4 Departments of Otorhinolaryngology—Head and
Neck Surgery, University of Pennslyvania, Philadelphia, PA, USA, 5 Department of Anesthesiology and Critical Care Medicine,
Perelman School of Medicine, University of Pennslyvania, Philadelphia, PA, USA
Edited by:
Yun-Qing Li,
The Fourth Military Medical
University, China
Reviewed by:
Nobuaki Tamamaki,
Kumamoto University, Japan
Owen Kavanagh,
Queens University Belfast, UK
*Correspondence:
Guoxiang Xiong
xiong@email.chop.edu
Received: 23 March 2016
Accepted: 02 May 2016
Published: 13 May 2016
Citation:
Mao S, Xiong G, Zhang L, Dong H,
Liu B, Cohen NA and Cohen AS
(2016) Verification of the Cross
Immunoreactivity of A60, a Mouse
Monoclonal Antibody against
Neuronal Nuclear Protein.
Front. Neuroanat. 10:54.
doi: 10.3389/fnana.2016.00054
A60, the mouse monoclonal antibody against the neuronal nuclear protein
(NeuN), is the most widely used neuronal marker in neuroscience research
and neuropathological assays. Previous studies identified fragments of A60-
immunoprecipitated protein as Synapsin I (Syn I), suggesting the antibody will
demonstrate cross immunoreactivity. However, the likelihood of cross reactivity has
never been verified by immunohistochemical techniques. Using our established tissue
processing and immunofluorescent staining protocols, we found that A60 consistently
labeled mossy fiber terminals in hippocampal area CA3. These A60-positive mossy
fiber terminals could also be labeled by Syn I antibody. After treating brain slices with
saponin in order to better preserve various membrane and/or vesicular proteins for
immunostaining, we observed that A60 could also label additional synapses in various
brain areas. Therefore, we used A60 together with a rabbit monoclonal NeuN antibody to
confirm the existence of this cross reactivity. We showed that the putative band positive
for A60 and Syn I could not be detected by the rabbit anti-NeuN in Western blotting.
As efficient as Millipore A60 to recognize neuronal nuclei, the rabbit NeuN antibody
demonstrated no labeling of synaptic structures in immunofluorescent staining. The
present study successfully verified the cross reactivity present in immunohistochemistry,
cautioning that A60 may not be the ideal biomarker to verify neuronal identity due to its
cross immunoreactivity. In contrast, the rabbit monoclonal NeuN antibody used in this
study may be a better candidate to substitute for A60.
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INTRODUCTION
Neuronal nuclear protein (NeuN) has been characterized as a neuron-specific nuclear
deoxyribonucleic acid (DNA)-binding regulatory molecule (Mullen et al., 1992). Using repeated
immunization with purified nuclei from neurons, a mouse monoclonal antibody was generated and
named A60 (Mullen et al., 1992). The mouse monoclonal antibody is capable of labeling neurons
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out of mitotic stages in different species of vertebrates (Mullen
et al., 1992; Rodriguez et al., 2002; Tonchev et al., 2003; Kumar
and Buckmaster, 2007; Korzhevskii et al., 2009; Verdiev et al.,
2009). However, A60 has shown a lack of labeling for cerebellar
Purkinje cells, olfactory mitral cells and retinal photoreceptor
cells (Mullen et al., 1992). Further neuronal exceptions may
include cerebellar interneurons (Weyer and Schilling, 2003)
and a subset of substantia nigral neurons (Weyer and Schilling,
2003; Kumar and Buckmaster, 2007; Cannon and Greenamyre,
2009; Korzhevskii et al., 2009; Verdiev et al., 2009).Highly
specific for labeling postmitotic neurons, A60 has been most
widely used neuronal marker in neuroscience research and
neuropathological assays (Gusel’nikova and Korzhevskiy, 2015).
The spectrum of A60 use is very broad including labeling
to monitor neuronal development (Wynder et al., 2005),
neurogenesis (Magavi et al., 2000) and stem cell differentiation
(Brazelton et al., 2000). NeuN imunoreactivity can also be used
as a biomarker for diagnosis of central neurocytoma (Wolf et al.,
1996). Furthermore, studies have suggested that quantitative
changes in NeuN immunoreactivity can be a determinant of
neuronal loss in several pathologies including neurodegenerative
diseases (Tippett et al., 2007), ischemia (Korzhevskii et al.,
2009), axotomy (McPhail et al., 2004) and traumatic brain
injury (Igarashi et al., 2001). However, Unal-Cevik et al.
(2004) has cautioned that loss of NeuN immunoreactivity
after cerebral ischemia might not directly indicate neuronal
cell loss. That is, it is likely that some pathologies will alter
the antigen-antibody interaction. For example, altering NeuN
protein phosphorylation leads to diminished reactivity with
A60 (Lind et al., 2005).NeuN is a soluble nuclear protein,
delineated as two to three bands at 46–48 kilo-dalton (kD)
as demonstrated by Western blotting (Mullen et al., 1992).
These bands have been identified as Fox-3 protein, a member
of Fox-1 gene family of splicing factors (Kim et al., 2009).
Furthermore, immunoprecipitation with Millipore A60 pulled
down two additional protein bands near 70 kD (Kim et al.,
2009; Maxeiner et al., 2014). The proteins pulled down with A60
were identified as Synapsin I (Syn I) using mass spectrometry;
thereby, suggesting cross reactivity of the NeuN antibody.
Surprisingly, this cross immunoreactivity between A60 and
Syn I could only be observed using Western blotting and
was never observed using standard immunohistochemical
staining in paraffin-embedded brain slices (Kim et al., 2009;
Maxeiner et al., 2014). Here we succeeded in revealing
A60 cross immunoreactivity by processing brain tissues
differently and performing free floating immunofluorescent
staining in vibratome prepared slices. We also used a
rabbit monoclonal antibody against NeuN to verify the
cross reactivity.
MATERIALS AND METHODS
Six to eight week old male mice (C57/Bl6, Jackson Laboratory,
Bar Harbor, ME, USA) were used. The procedures and
protocols for all animal studies were approved by Institutional
Animal Care and Use Committees of Wuhan University,
Children’s Hospital of Philadelphia and University of
Pennsylvania, in accordance with international guidelines
on the ethical use of animals (National Research Council,
1996). All immunostaining and Western blotting was
undertaken in three animals in order to verify a distribution
pattern.
Immunofluorescent Staining
For all immunofluorescent experiments, we used our own
published protocols (Xiong et al., 2012, 2015; Yuan et al.,
2015). For free floating immunofluorscent staining, 15 mice
were deeply anesthetized with 0.4 ml of 5% chloral hydrate and
perfused with normal saline followed by 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.4). Brains were removed and
post-fixed for 90 min at room temperature (RT). Brains were
kept in PBS at 4◦C before frontal slices (50 µm thickness)
were cut with a Leica VT 1000s vibratome (Leica Microsystems
Inc., Buffalo Grove, IL, USA). To minimize the number of
animals sacrificed, brain slices were collected in six series
for different immunostaining settings with an interval of
300 µm between two adjacent slices within an identical series
(Xiong et al., 2012). The slices were permeabilized with 0.3%
Triton X-100 and blocked with a mixture of 5% normal goat
serum and 1% bovine serum albumin at RT for 60 min,
respectively.
For single immunofluorescent staining, slices were incubated
with a mouse or rabbit antibody for 90 min at RT followed
by overnight at 4◦C. For visualization, we used Alexa Fluor
488-conjugated goat anti-mouse IgG or Alexa Fluor 594-
conjugated goat anti-rabbit IgG (Both at 1:250 in PBS; Life
Technology, Grand Island, NY, USA) at RT for 60 min.
The nuclear dye Hoechst (Life Technology, Grand Island,
NY, USA) was added to the secondary antibody solution
in order to counterstain the samples. For double staining,
we incubated the brain slices with a mouse and a rabbit
antibody simultaneously. For visualization, a mixture of Alexa
Fluor 488-conjugated goat anti-mouse IgG (green) and Alexa
Fluor 594-conjugated goat anti-rabbit IgG (rabbit) were used,
together with Hoechst (blue). Procurement and working
dilution for the antibodies are listed in Table 1. For imaging
with Olympus Fluoview 1000 system (Olympus America,
Center Valley, PA, USA), we applied the same confocal
settings as previously published (Xiong et al., 2012). Brain
structure nomenclature was derived from Paxinos and Franklin
(2001).
Western Blot
Three mice were anesthetized with isoflurane and subsequently
decapitated. The entire protocol for protein extraction was
performed on ice. The brains were removed and submerged
in cold saline. Each hippocampus (HC) was immediately
dissected out and chopped into three pieces. The hippocampal
tissue blocks were collected in lysis buffer containing 50 mM
Tris, 1mM EDTA, 150 mM NaCl, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS and 1% protease inhibitor
(Sigma-Aldrich, St. Louis, MO, USA). As a control, cortical
tissue blocks were also collected into a separate tube. After
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TABLE 1 | List of antibodies used in the present study.
Antigen name Manufacture Cat. # Host Immunogen Original Dilution for Dilution for
(abbreviation) concentration immunostaining western blot
Neuronal
nuclear protein
(NeuN)
Zymed
(South San Francisco,
CA, USA)
18–7373
(Discontinued)
Mouse Mono
(A60)
Mouse brain
nuclei
100 µg/ml 1:500 N/A
NeuN Millipore (Billerica,
MA, USA)
MAB377 Mouse
Mono (A60)
Mouse brain
nuclei
1000 µg/ml 1:250 1:500
NeuN Abcam
(Cambridge, MA, USA)
ab177487 Rabbit Mono Human NeuN
aa 1–100
727 µg/ml 1:500 1:1000
Synapsin I (Syn I) Sigma
(St. Louis, MO, USA)
S193 Rabbit Poly Bovine
Synapsin I
200 µg/ml 1:500 1:1000
Vesicular
glutamate
transporter 1
(VGLUT1)
Synaptic Systems
(Goettingen, Germany)
135 302 Rabbit Poly Rat VGLUT1
aa 456–560
serum 1:2000 N/A
Vesicular GABA
transporter (VGAT)
Synaptic Systems 131 002 Rabbit Poly Rat GABA
aa 75–87
serum 1:250 N/A
Glial fibrillary acidic
protein (GFAP)
Abcam ab48050 Rabbit Poly Human GFAP
aa 1–400
1000 µg/ml 1:1000 N/A
Major information from manufactures and working dilution of each antibody were listed. Mono, monoclonal antibody; Poly, polyclonal antibody.
gentle homogenization with a pellet pestle, the homogenate
was sonicated at a level set at 15 for 20 s (5 s-on/3 s-off)
with a sonic dismembrator (Model 500, Fisher Scientific,
Pittsburgh, PA, USA). The resulting homogenate was centrifuged
at 15,000 g for 20 min. and the supernatant was collected.
Protein concentration was determined and the samples were
aliquoted and stored at −80◦C for subsequent Western
blotting.
Double fluorescent western blotting was performed after
staining patterns of target proteins was confirmed with single
blots. Equal amounts (by weight) of hippocampal or cortical
protein samples were separated with SDS-PAGE gel (7.5%)
electrophoresis and transferred to nitrocellulose membranes.
The membranes were blocked in PBST buffer (0.1% tween 20
in PBS) with 5% non-fat milk at RT for 60 min. They were
subsequently incubated with either a mixture of Millipore A60
and rabbit anti-NeuN, or Millipore A60 and rabbit anti-Syn
I in non-fat milk at 4◦C overnight. After washing thoroughly
in PBST, the membranes were incubated with a mixture of
Alexa Fluor 800 conjugated goat anti-mouse IgG (green) and
Alexa Fluor 680 conjugated goat anti-rabbit IgG (red) at RT for
60 min. Both secondary antibodies (Rockland Immunochemicals
Inc., Pottstown, PA, USA) were used at a 1:10,000 dilution
in non-fat milk. The fluorescent immunoblots were imaged
with Odyssey imaging system (Li-Cor Biosciences, Lincoln, NE,
USA).
RESULTS
“Unexpected” Synaptic Staining by
Millipore A60
To counterstain neuronal populations in the HC, cortex (CTX)
and other brain areas, we combined either the Zymed or
Millipore A60 antibody with additional antibodies for target
molecules. Neuronal nuclei as well as cell bodies were heavily
stained by both A60 antibodies, leaving nucleoli unstained
(Figure 1). Occasionally the proximal neurites were also labeled,
which often occurred in the CTX. Glia and blood cells/vessels
never demonstrated any labeling. Unexpectedly, Millipore A60
also labeled large sized punctate structures in hippocampal area
CA3, in addition to transversely truncated neurites adjacent
to pyramidal cell layer. These punctate structures could be
clearly identified even under low power magnification and
were distributed exclusively in stratum lucidum (sl) from
CA3c to CA3ab (Figures 1A,B), suggesting that they might
be mossy fiber terminals. The identical synaptic labeling
pattern was confirmed using different lots of Millipore A60. In
contrast, Zymed A60 did not label mossy fiber-like structures
(Figures 1C,D).
Synaptic Staining Confirmed with Millipore
A60 and Synaptic Markers
To reveal the identity of A60-positive punctate structures in sl,
we performed double immunofluorescent staining by combining
the Millipore A60 with a combination of different markers
(Figure 2). A perfect co-localization was demonstrated by
co-staining with VGLUT1 (Figures 2A,D–F), but not with
VGAT (Figure 2B) or GFAP (Figure 2C). As shown in high
magnification (Figure 2, Inset), these A60-positive puncta
(green) displayed rosette shapes ranging from 2 to 6 µm and
could be co-stained with VGLUT1 (red), suggesting that they
were mossy fiber terminal (Xiong et al., 2012).
Immunofluorescent Co-Staining and
Double Fluorescent Western Blotting with
Millipore A60 and Syn I Antibody
We also performed co-staining of Millipore A60 with a rabbit
polyclonal antibody against Syn I (Figure 3). The pan-synaptic
Frontiers in Neuroanatomy | www.frontiersin.org 3 May 2016 | Volume 10 | Article 54
Mao et al. Cross Reactivity of NeuN Antibody
FIGURE 1 | Comparison of Millipore A60 to Zymed A60 in immunofluorescent staining pattern. Confocal images from hippocampal area CA3ab subregion.
A60 from either Millipore (A,B) or Zymed (C,D) intensively labeled nuclei and somata of principal cells and inhibitory interneurons (arrows). Truncated proximal
neuropils were prominent adjacent to pyramidal cell layer (pcl). In addition to this common staining pattern, Millipore A60 also resulted in punctate staining in stratum
lucidum (sl), delineated by dots and asterisks (A). so, stratum oriens; sr, stratum radiatum. Scale bar: 10 µm in (A,C); 5 µm in (B,D).
marker Syn I resulted in intensive immunostaining in sl and
weak labeling in other hippocampal subregions (Figures 3B,E).
In sl where mossy fiber terminals were intensively stained
by A60 (Figures 3A,D), a perfect colocalization was evident
(Figures 3C,F, Insets).
We then conducted double fluorescent Western blotting with
both antibodies using protein samples extracted from the HC,
to determine if the bands close to 74 kD could be labeled by
both Millipore A60 and Syn I, as reported previously (Kim et al.,
2009; Maxeiner et al., 2014). Our Western blotting protocol
using Millipore A60 labeled two bands at approximately 50 kD
and another wide band at approximately 75 kD (Figure 4A).
Syn I labeling showed an intensively stained wide band near
75 kD (Figure 4B). A perfect co-staining was clearly identified
in the band at approximately 75 kD (Figure 4C, yellow), leaving
two bands around 50 kD exclusively labeled by A60 only.
Surprisingly, the co-stained band near 75 kD was also apparent
in protein samples from the CTX (Figure 4).
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FIGURE 2 | Millipore A60-positive punctate structures might be hippocampal mossy fiber terminals. Confocal images from CA3ab after double
immunofluorescent staining with Millipore A60 and different markers. When double stained with Millipore A60 and VGLUT1, costaining could be clearly identified in
punctate structures in sl (A, yellow). These Millipore A60-positive puncta were negative to VGAT (B) or GFAP (C). Under higher magnification (D–F), rosette-shaped
structures were intensively stained by both Millipore A60 and VGLUT1, showing a perfect localization (Insets). Arrows indicate rosettes magnified. Scale bar: 10 µm
in (A–C); 5 µm in (D–F); 2 µm in Insets.
Saponin Treatment Improved Synaptic
Staining by Millipore A60
The identification of the co-stained 75 kD band from cortical
samples lead us to assess A60 synaptic staining carefully in the
whole brain using high power magnification. In addition to
mossy fibers in sl of area CA3, hippocampal area CA1 was the
only further area demonstrating A60-positive punctate staining,
ranging between 0.5 to 1 µm (Figure 5A). These A60-positive
small synaptic structures were mainly distributed in stratum
radiatum and/or lacunosum-moleculare, likely along pyramidal
neuronal dendritic arbors. In the CTX as well as other brain
regions, no synaptic staining by Millipore A60 was evident
(Figure 5C).
Considering that other synaptic structures might not be well
preserved forMillipore A60 immunostaining under our standard
protocol, we replaced Triton X-100 with saponin in order to keep
more vesicular proteins prior to immunostaining as previously
reported (Goldenthal et al., 1985). Compared to the Triton X-100
treated brain slices (Figures 1–3), saponin treatment enhanced
synaptic staining by Millipore A60 in the HC (Figure 5B), CTX
(Figures 5C,D), thalamus and other areas of the brain (data not
shown).
Double Fluorescent Western Blot and
Immunofluorescent Co-Staining with
Millipore A60 and a Rabbit Monoclonal
Antibody Against NeuN
To verify the cross immunoreactivity, we performed double
fluorescent Western blotting (Figures 4D–F) as well as
immunofluorescent co-staining (Figure 6) with Millipore A60
and a rabbit monoclonal antibody against NeuN. The rabbit
monoclonal anti-NeuN labeled two bands at approximately
50 kD (Figure 4E) in both CTX and HC. These bands were
perfectly matched with the bands labeled by A60 (Figure 4F).
However, the band at approximately 75 kD was labeled with
Millipore A60 (Figure 4D) but no labeling was evident with the
rabbit anti-NeuN (Figures 4E,F).
Double immunohistochemical labeling demonstrated that the
rabbit anti-NeuN specifically labeled neuronal nuclei/cell bodies
as efficiently as Millipore A60 (Figure 6A, white or off-white).
No punctate structures were stained by the rabbit anti-NeuN,
thus mossy fiber terminals were solely labeled by Millipore
A60 only (Figure 6A, arrowheads) evident as pure green
puncta (Figures 6B–E). The rabbit anti-NeuN antibody labeled
more truncated neuropils of hippocampal principal neurons
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FIGURE 3 | Colocalization of Synapsin I (Syn I) in Millipore A60-positive mossy fiber terminals. (A–C) Stacked confocal images showing distribution pattern
of Millipore A60 (A) and Syn I (B) staining in CA3ab. In addition to large-sized mossy fiber terminals in sl (C), Syn I-positive small puncta were also visible in sr, pcl
and so (B,C). (D–F) Confocal images under higher magnification showing perfect colocalization (yellow) in mossy fiber terminals. Arrows indicating rosette-shaped
mossy fiber terminals highlighted in Insets. Scale bar: 10 µm in (A–C); 5 µm in (D–F); 2 µm in Insets.
(Figure 6D), perhaps due to the lack of synaptic staining in the
area. Sheath-like arrangements (Figure 6E, Inset) of A60 positive
mossy fiber terminals (green) were prominent, surrounding
truncated neuropils (orange to yellow).
To test if triton treatment might diminish the rabbit anti-
NeuN synaptic labeling as occurred with the Millipore A60
antibody, we once again conducted double immunostaining in
brain slices treated with saponin. In contrast to Millipore A60-
positive synaptic staining (green) in sl and sr (Figure 7A),
no synaptic staining by the rabbit NeuN antibody (red)
was evident in either subregion (Figure 7B). Furthermore,
no co-staining could be identified in synaptic structures
(Figures 7A–C, Insets), except for double labeled neuronal
cell bodies/nuclei (Figure 7C). Compared to treatment with
Triton X-100 (Figure 6D), saponin treatment demonstrated
more truncated neuropiles by the rabbit anti-NeuN (Figure 7B),
resulting more sheath-like arrangements, even in the distal sl
(Figure 7, Inset 2).
DISCUSSION
Our established immunofluorescent staining protocol applied
in vibratome prepared brain slices (Xiong et al., 2012, 2015;
Yuan et al., 2015), was used to counterstain neuronal cell
groups with Zymed A60, a monoclonal antibody against NeuN.
This antibody intensively labeled nuclei and cell bodies of
principal neurons and inhibitory interneurons in similar fashion
to that reported by Mullen et al. (1992), without nonspecific
labeling of glia, blood cells or vessels. Since the Zymed A60
antibody had been discontinued, we necessarily needed to
use the Millipore A60 antibody. The Millipore monoclonal
resulted in a similar staining pattern of neuronal cell bodies
and nuclei. However, we encountered ‘‘unexpected’’ labeling
of punctate structures in sl of hippocampal area CA3, which
is known as the termination target of hippocampal mossy
fibers (Amaral and Witter, 2000). Based on the size (2–6 µm),
location (sl), morphology (rosette-shape) and immunoreactivity
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FIGURE 4 | Double fluorescent Western blotting using Millipore A60 and rabbit antibody against Syn I or NeuN. (A–C) Millipore A60 detected two bands
around 50 kilo-dalton (kD) and a single wide band close to 75 kD (A) in both hippocampus (HC) and cortex (CTX), while Syn I antibody intensively stained a wide
band near 75 kD (B). Perfect co-staining was clearly identified in the band near 75 kD (C). (D–F) The rabbit anti-NeuN recognized two bands around 50 kD (E) and
co-staining by both NeuN antibodies was identified in these two bands (F), leaving the band near 75 kD positive for Millipore A60 only (D,F). Arabic numerals
indicate the size (in kD) of markers.
(positive for VGLUT1), these Millipore A60-positive punctate
structures were thought to be mossy fiber terminals (Amaral
and Witter, 2000; Xiong et al., 2012). The present study
demonstrated that the two A60 antibodies from different
sources s might give rise to different labeling patterns, even
though both antibodies were generated from same hybridoma
clone originally developed by Mullen et al. (1992). Furthremore,
due to the unavailability of the Zymed A60 antibody, we
could not determine the source of the differences in synaptic
staining.
Previous Western blotting with the Millipore A60 antibody
resulted in two protein bands at approximately 74 kD (Kim
et al., 2009; Maxeiner et al., 2014). Using mass spectrometry
these bands has been identified as Syn I, suggesting that
A60 cross reacts with the Syn I protein. The authors (Kim
et al., 2009) had to use whole cell extracts from neurons (but
not the original immunogen, i. e. purified neuronal nuclear
extracts) to detect the putative Syn I bands, confirming that
the target protein (i.e., Syn I) involved in the cross reactivity
was not a nuclear component. In the present study we
show a single band of similar size, possibly due to a lower
separating efficiency of our SDS-Page gel electrophoresis. This
band could be labeled with both Syn I antibody and A60,
supporting the notion of A60 cross reactivity (Kim et al.,
2009; Maxeiner et al., 2014). The present and previous (Kim
et al., 2009; Maxeiner et al., 2014) data obtained with Western
blotting led us to perform double immunofluorescent labeling.
Interestingly, we found a perfect co-localization of Syn I in
Millipore A60-positive mossy fiber terminals, contradicting
previous reports that cross reactivity has not been supported
by immunohistochemical experimentation conducted in fixed
brains (Kim et al., 2009; Maxeiner et al., 2014; Gusel’nikova and
Korzhevskiy, 2015).
The quality of immunohistochemical staining may be
largely dependent on fixation, tissue processing/sectioning,
permeabilizing reagents, and the quality and concentration of the
primary antibody (Werner et al., 2000; Bussolati and Leonardo,
2008; Shi et al., 2008; Fung and Tam, 2010; Xiong et al., 2015;
Yuan et al., 2015). We note that previous studies investigating
possible A60 cross reactivity were performed on paraffin-
embedded slices (Kim et al., 2009; Maxeiner et al., 2014). Further,
it has been suggested that the Syn I proteinmight be vulnerable to
the necessary tissue processing for paraffin embedding including
heating, alcoholic dehydration and xylene dewaxing (Maxeiner
et al., 2014). Moreover, over fixation of brain tissue might be
the key factor attributing to the negative staining of synaptic
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FIGURE 5 | Synaptic staining from Millipore A60 could be improved by saponin treatment. Stacked confocal images showing immunostaining pattern.
Hippocampal area CA1 was the only region showing clear punctate staining of small synapses (0.5–1 µm) in slices treated with Triton X-100 (A). (B) Clear staining of
small synapses in sr (B) of area CA3 after saponin treatment. Compared to treatment with Triton X-100 (C), saponin treatment also improved synaptic staining from
Millipore A60 in the CTX (D). Scale bar: 5 µm in (A,C,D); 10 µm in (B).
structures. Unlike 90 min used in the current study for post-
fixation in paraformaldehyde (Xiong et al., 2012, 2015; Yuan
et al., 2015), previous studies post-fixed brains for 12 h overnight
or even up to 48 h (Kim et al., 2009; Maxeiner et al., 2014). It has
previously demonstrated that aldehyde fixatives can cross-link
specific amino acid residues and thus alter a protein’s quaternary
structure (Puchtler and Meloan, 1985; Metz et al., 2004; Toews
et al., 2008). Therefore, excessive fixationmight result inmuffling
the epitopes of the target proteins. Coincidently, the core epitope
in Syn I for A60 reaction ismore likely to bemodified by aldehyde
fixation (Maxeiner et al., 2014). It is worthy to mention that
our Syn I labeling demonstrated both mossy fiber terminals and
small-sized synapses in triton-treated slices (Figure 3). However,
labeling with Millipore A60 did not demonstrate small synapses
in the same slices, indirectly supporting the notion put forth
by Kim et al. (2009) that A60 has a lower affinity for Syn I
protein.
Like the pan-presynaptic marker synaptophysin (Xiong et al.,
2012), Syn I should be expressed all over the brain, suggesting
that the cross immunoreactivity of A60 should exist in other
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FIGURE 6 | Comparison of Millipore A60 (green) to the rabbit anti-NeuN (red) by double immunofluorescent costaining. (A) Staining pattern in the whole
HC. Principal cells and interneurons were intensively stained by both antibodies, exhibiting white or off-white appearance due to the addition of counterstaining with
Hoechst (blue). Punctate staining was prominent along mossy fiber pathway (arrowheads), stained by Millipore A60 only (green). DG, dentate gyrus. (B) Stacked
confocal images showing distribution pattern stained by both NeuN antibody in CA3ab. Whereas double stained neuronal nuclei and cell bodies (yellow) were
prominent in pcl, mossy fiber terminals were positive to Millipore A60 only (green), highlighted in sl. (C–E) Single confocal image under higher magnification showing
double stained mossy fiber terminals. (Inset) Rosette-shaped mossy fiber terminals encircling truncated neuropils to form sheath-like arrangements, highlighted from
the area indicated by Arrow. Scale bar: 50 µm in (A); 10 µm in (B); 5 µm in (C–E); 2 µm in Inset.
brain regions in addition to the HC. Western blotting in
cortical samples demonstrated co-staining with Millipore A60
and Syn I antibodies in the 75 kD band. However, our synaptic
staining by Millipore A60 could only be observed within the
HC. This inconsistency might be due to a yet to be identified
factor(s) muffling other regions from immunostaining. It has
been suggested that Triton X-100 use leads to artificial loss
of some antigens and therefore saponin might be a better
detergent for preparation for immunohistochemical labeling of
membranous or vesicular proteins (Goldenthal et al., 1985). The
use of Triton X-100 might diminish Syn I cross reactivity with
Millipore A60 in most synapses, except for hippocampal mossy
fiber terminals (with large volume) and small-sized synapses
along CA1 pyramidal cell dendrite trees (with high density).
Interestingly, saponin use led to robust labeling of small-sized
synapses all over the brain including HC, CTX, thalamus as well
as other regions of the brain. However, saponin might not be
strong enough to permeate the thick slices used in the present
study, because the labeling all occurred within a short range from
brain slice surfaces (data not shown).
Technically, when neuronal nuclei (around 5 µm) and cell
bodies were in focus, tiny synapses (less than 1 µm) might
be easily ignored unless rigorously examined with high power
objectives. Due to the large size, Millipore A60-positive mossy
fiber terminals could be easily identified as a curved band along
CA3c to CA3ab, even under low power objectives (Figure 6A). In
fact, A60-stained small synapses in area CA1 could not be clearly
identified until examined with 63× objective.
To definitively verify antibody cross immunoreactivity, one of
the following suggestions should be followed. Negative staining
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FIGURE 7 | No synaptic staining could be achieved by the rabbit anti-NeuN after saponin treatment. Single confocal image taken from area CA3ab
showing double staining with Millipore A60 and the rabbit anti-NeuN. Whereas Millipore A60 (green) stained out mossy fiber terminals in sl and small synapses in sr
(A), truncated neuropils stained by the rabbit NeuN antibody (red) were prominent in both proximal and distal sl (B). Colocalization (yellow) could be seen exclusively
in nuclei and somata of principal cells and inhibitory interneurons (C). No staining by the rabbit anti-NeuN was found either in small synapses from sr (Inset 1), or in
mossy fiber terminals from sl (Inset 2). Arrow shows the area of small synapses in sr. Arrowhead indicates mossy fiber terminals forming sheath-like arrangements,
even to distal sl. Scale bar: 5 µm in (A–C); 2 µm in Insets.
with gene knockout samples or co-staining with two antibodies
raised from different animal species and designed to recognize
different epitopes of the target protein (Lorincz andNusser, 2008;
Saper, 2009; Xiong et al., 2015). Since it is impossible to generate a
knockout NeuN animal due to its biological importance (Dredge
and Jensen, 2011; Kim et al., 2011, 2013), we followed the
second suggestion using the mouse monoclonal (Millipore A60)
immunized by purified neuronal nuclei together with a rabbit
monoclonal antibody immunized by synthetic peptide of human
NeuN protein. We demonstrated that synaptic staining could
be identified by Millipore A60 but not by the rabbit anti-NeuN
in slices treated with or without saponin, suggesting that the
cross reactivity might come from the epitope corresponding to
the 75 kD band (Syn I) rather than approximately 50 kD bands
(Fox-1). The verification of the cross reactivity of Millipore A60
was also supported by our Western blotting data demonstrating
the Millipore A60-positive band near 75 kD could not be
stained by the rabbit anti-NeuN. It has been a long-term
quandary that A60 cross reactivity could be confirmed by
immunochemical but not immunohistological techniques (Kim
et al., 2009; Maxeiner et al., 2014; Gusel’nikova and Korzhevskiy,
2015). The present study sheds some interesting evidence on this
issue.
In summary, Millipore A60 should not be solely used to prove
neuronal identity due to the potential cross immunoreactivity
demonstrated in the present and previous studies (Kim et al.,
2009; Maxeiner et al., 2014). Without similar cross reactivity,
the rabbit monoclonal NeuN antibody tested here may be better
suited than A60. Alternatively, a careful verification with an
additional NeuN antibody is necessary when attempting to
interpret immunostaining labeling with Millipore A60.
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